NCT00348179

Brief Summary

The objectives of this investigator initiated study are to:

  1. 1.Determine if and when vascular abnormalities occur during early adolescence
  2. 2.Determine if poor diabetic control is related to vascular abnormalities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2004

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2004

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

June 30, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 4, 2006

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2007

Completed
Last Updated

January 24, 2008

Status Verified

April 1, 2007

Enrollment Period

3 years

First QC Date

June 30, 2006

Last Update Submit

January 23, 2008

Conditions

Type 1 Diabetes

Keywords

Vascular abnormalitiesType 1 diabetesHealthy control subjects

Outcome Measures

Primary Outcomes (1)

  • Vascular abnormalities as measured by the SyphmgnoCor equipment

    End of study

Interventions

Measurement of vascular function per SphymgnoCor equipmentPROCEDURE

Pressure tonometer will be used on various vessels, non-invasive.

Eligibility Criteria

Age12 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Boys and girls ages 12-14 years who have Type 1 diabetes or are healthy controls

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Mercy Hospital

Kansas City, Missouri, 64108, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Kurt Midyett, MD

    Children's Mercy Hospital Kansas City

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 30, 2006

First Posted

July 4, 2006

Study Start

April 1, 2004

Primary Completion

April 1, 2007

Study Completion

April 1, 2007

Last Updated

January 24, 2008

Record last verified: 2007-04

Locations

US(1)